West Pharmaceutical Services Inc (BSP:W2ST34)
R$ 52.6 (0%) Market Cap: 130.07 Bil Enterprise Value: 129.02 Bil PE Ratio: 47.29 PB Ratio: 8.39 GF Score: 89/100

West Pharmaceutical Services Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 05:00PM GMT
Release Date Price: R$40.76
Fawzi Kawash
JPMorgan - Analyst

Good morning, all, and welcome. My name is Fawzi Kawash, and I'll be moderating today's session. It is my pleasure to introduce Eric Green, President, CEO and Board Chair; Bob McMahon, CFO; and John Sweeney, VP of IR of West to the JPMorgan conference.

And without further ado, I'll hand it over to Eric.

Eric Green
West Pharmaceutical Services Inc - Non-Independent Chairman of the Board, President, Chief Executive Officer

All right. Fawzi, thank you so much for the introduction, and thank you for the invitation for the JPMorgan Conference. Happy New Year to everybody, and it's a great start to 2026. Before I get started into the West discussion, I want to just reference the safe harbor statement that's found on this presentation, also found at our website at westpharma.com. I'm going to talk a little bit about West.

It's a phenomenal story over several decades of where we are today, but more importantly, where we're going. If you think of from an investment portfolio perspective, we are the global leader in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot